![Anja Pomrehn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anja Pomrehn
Investor Relations Contact chez MEDACTA GROUP SA
Profil
Anja Pomrehn formerly worked at Clariant AG, as Head-Investor Relations and MorphoSys AG, as Head-Investor Relations.
Dr. Pomrehn received her graduate degree and Masters Business Admin degree from the University of London and doctorate degree from the University of Zurich.
Dernières actualités sur Anja Pomrehn
Postes actifs de Anja Pomrehn
| Sociétés | Poste | Début |
|---|---|---|
| MEDACTA GROUP SA | Investor Relations Contact | 21/11/2024 |
Anciens postes connus de Anja Pomrehn
| Sociétés | Poste | Fin |
|---|---|---|
| MORPHOSYS AG | Investor Relations Contact | - |
| CLARIANT AG | Investor Relations Contact | - |
Formation de Anja Pomrehn
University of Zurich | Doctorate Degree |
University of London | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CLARIANT AG | Process Industries |
| MEDACTA GROUP SA | Health Technology |
| Entreprise privées | 1 |
|---|---|
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology MorphoSys AG is a biopharmaceutical company, which engages in the development and commercialization of cancer therapeutics. Its clinical programs focus on Pelabresib and Tulmimetostat. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany. | Health Technology |
